3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Advanced Solid Tumors
69
Advanced Solid Tumor
58
Solid Tumor
50
Solid Tumors
42
Mesothelioma
39
Mesothelioma, Malignant
36
Hematopoietic and Lymphatic System Neoplasm
24
Solid Tumor, Adult
15
Ovarian Neoplasms
13
Malignant Solid Neoplasm
13
Carcinoma, Non-Small-Cell Lung
13
Melanoma
12
Pancreatic Neoplasms
11
Sarcoma
10
Retinoblastoma
9
Colorectal Neoplasms
9
Stomach Neoplasms
8
Lung Neoplasms
8
Advanced Malignant Solid Neoplasm
8
Solid Tumours
7
Small Cell Lung Carcinoma
7
Cholangiocarcinoma
7
Carcinoma, Renal Cell
7
Advanced or Metastatic Solid Tumors
7
Kidney Neoplasms
6
Carcinoma, Hepatocellular
6
Advanced/Metastatic Solid Tumors
6
Advanced Malignant Solid Tumor
6
Uterine Cervical Neoplasms
5
Urinary Bladder Neoplasms
5
Interventions
temsirolimus
1
Cetuximab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Patients With Advanced or Metastatic Solid Tumors
×
Other solid neoplasm
×
90 days
×
Clear all
NCT02215720
2026-03-20
TORERO
Gustave Roussy, Cancer Campus, Grand Paris
Phase 1
Completed
45 enrolled